NewAmsterdam Pharma Company N.V. (NAMS) Earnings
NASDAQ·Healthcare·Biotechnology
$27.25
-0.89%
Mkt Cap $3.26B
EPS — Estimate vs Actual
Mkt Cap
$3.26B
P/E
—
Fwd P/E
—
P/S
144.60
Rev TTM
—
EPS TTM
-$1.81
NASDAQ·Healthcare·Biotechnology
$27.25
-0.89%
Mkt Cap $3.26B
Mkt Cap
$3.26B
P/E
—
Fwd P/E
—
P/S
144.60
Rev TTM
—
EPS TTM
-$1.81